Anke Sparmann
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 2
- RNA regulation and disease 2
- CRISPR and Genetic Engineering 2
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- RNA and protein synthesis mechanisms 2
- Oncology 2
- Chemokine receptors and signaling 2
- Co-authors
- Maarten van Lohuizen (2 shared papers)Dafna Bar‐Sagi (2 shared papers)Jörg Vogel (2 shared papers)Els Verhoeven (1 shared paper)Cesare Lancini (1 shared paper)Gaetano Gargiulo (1 shared paper)Matthias Mann (1 shared paper)Yunli Xie (1 shared paper)
- Journals
- Nature Structural & Molecular Biology (3 papers)The EMBO Journal (2 papers)RNA (1 paper)Cancer Cell (1 paper)Nature reviews. Cancer (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Anke Sparmann
9 papers receiving 1.8k citations
Anke Sparmann's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 383
- Oncology 502
- Molecular Biology 1.3k
- Immunology 344
- Immunology and Allergy 47
Countries citing papers authored by Anke Sparmann
This map shows the geographic impact of Anke Sparmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Sparmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Sparmann more than expected).
Fields of papers citing papers by Anke Sparmann
This network shows the impact of papers produced by Anke Sparmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Sparmann. The network helps show where Anke Sparmann may publish in the future.
Co-authors
The 14 scholars most cited alongside Anke Sparmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polycomb silencers control cell fate, development and cancer Hit paper breakdown → | 2006 | 1031 |
| 2 | Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis Hit paper breakdown → | 2004 | 667 |
| 3 | 2023 | 74 | |
| 4 | 2013 | 70 | |
| 5 | 2005 | 17 | |
| 6 | 2025 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2019 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2015 | 0 |
About Anke Sparmann
Anke Sparmann is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Ecology, having authored 10 papers that have together received 1.9k indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (2 papers), Epigenetics and DNA Methylation (2 papers), Chemokine receptors and signaling (2 papers), RNA regulation and disease (2 papers), CRISPR and Genetic Engineering (2 papers), RNA modifications and cancer (2 papers), RNA Research and Splicing (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Cancer Research (383 citations), Oncology (502 citations), Molecular Biology (1.3k citations), Immunology (344 citations) and Immunology and Allergy (47 citations). Anke Sparmann has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Maarten van Lohuizen, Dafna Bar‐Sagi, Jörg Vogel, Els Verhoeven, Cesare Lancini, Gaetano Gargiulo, Matthias Mann, Yunli Xie, Juergen A. Knoblich and Danielle Hulsman. Their work appears in journals such as Nature Structural & Molecular Biology, The EMBO Journal, RNA, Cancer Cell and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.